Nakom (Carbidopa, Levodopa)

Carbidopa/Levodopa, the active ingredient in Nakom, is an Antiparkinson agent presented as an oral tablet for oral use. It is used to manage the motor symptoms of Parkinson's disease in adults by restoring dopamine activity in the brain. The combination works by increasing central levodopa availability while reducing peripheral side effects, providing more consistent symptom control.

GNH USA supplies Nakom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nakom (carbidopa/levodopa) is used in the management of Parkinsonian disorders, targeting dopaminergic deficiency.

- Parkinson's disease (idiopathic): improves motor function, reduces rigidity and bradykinesia. - Parkinson's disease (advanced): lessens off‑periods and enhances daily activity tolerance. - Parkinsonian syndrome secondary to drug toxicity or vascular causes: provides symptomatic relief of motor deficits.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Vomiting: occasional episodes, especially after dose initiation. - Dizziness: may occur with postural changes. - Orthostatic hypotension: drop in blood pressure upon standing. - Headache: transient tension‑type headaches. - Insomnia: difficulty initiating sleep.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements that can be disabling. - Psychosis or hallucinations: visual disturbances, especially in older patients. - Severe hypotension: marked blood pressure fall requiring medical attention. - Cardiac arrhythmias: irregular heart rhythms in susceptible individuals. - Neuroleptic malignant syndrome: rare but life‑threatening reaction when combined with dopamine antagonists.

Before initiating therapy, consider the following precautions: - Monitor blood pressure: orthostatic hypotension may increase fall risk. - Assess psychiatric history: patients with psychosis may experience worsening symptoms. - Review hepatic and renal function: dose adjustments may be needed in impairment. - Evaluate concomitant medications: dopamine antagonists can reduce efficacy. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and light.

Carbidopa/levodopa may interact with several drug classes.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): antagonize dopamine, reducing therapeutic effect. - Pyridoxine (vitamin B6) without carbidopa: increases peripheral levodopa metabolism. - High‑protein meals: can impair levodopa absorption.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance hypotensive effects. - Selective serotonin reuptake inhibitors: monitor for rare serotonin syndrome. - Iron or calcium supplements: may decrease levodopa bioavailability if taken simultaneously.